Zhangzhou Pientzehuang Pharmaceutical | 600436 - Cash And Equivalent


Zz Pientze Pharmaceu reported CNY1.77B in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Jiangsu Hengrui CNY 40.36B 4.24B Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Moderna USD 1.13B 147M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Sh Fosun Pharma CNY 11.48B 1.48B Sep/2025
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Viatris USD 975.3M 408.9M Sep/2025
Wuxi Apptec CNY 29.44B 7.95B Sep/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025